Evaluation Of Adherence To The Use Of Anti-Diabetic Medicine In Type 2 Diabetes Mellitus Patient At Primary Health Care Gombong 1
Keywords:
diabetes, adherence, treatmentAbstract
Background, Diabetes is a chronic metabolic nuisance disease that is signed by a high level of blood sugar more than a normal level. For diabetes mellitus type 2 patient, medicine consumption adherence is a very important thing to control the level of blood sugar in order to stay stable and decrease the complication risk. Research purpose, To know patient characteristic correlation including gender, age, education level, occupation, income, suffering duration, the amount of medicine that is used, complication, by adherence level of the use of anti-diabetes medicine. Research method, Quantitative analysis used a cross-sectional design. The sampling technique used total sampling. the sample used is 62 respondents. The adherence level was measured by the MMAS-8 questionnaire. Data analysis used the Chi-Square test and Ordinal Logistic Regression test. Research result, The adherence level of the use of anti-diabetes medicine in the non-adherence category are 30 respondents (48,4), quite adherence are 21 respondents (33,9), and adherence category are 11 respondents (17,7). Base on Chi-Square test result, there is a significant correlation between age group and adherence level (p=0,034) and there is no a significant correlation between gender (p=0,733), education level (p=0,891), occupation (p=0,059), income (p=0,830), suffering duration (p=0,610), complication disease (p=0,759), and the amount of medicine that is used (p=0,373) with the adherence level. The result of multivariate analysis shows age group 45-60 years old is a dominant factor that has an influence on the level of non-adherence use of medicine with a value of p=0.034 (OR=0.292, 95CI=0.091-0.939). Conclusion, Patients are classified as non-adherence to the use of anti-diabetes medicine (48,4). There is a significant correlation between age group and the adherence level. The age group 40-60 years old is a dominant factor that influences the non-adherence to the use of anti-diabetes medicine. Suggestion, Further research is needed to use a bigger sample, research the family support factor with the adherence level of the use of anti-diabetes medicine, and analyze the long-suffering factor with the level of adherence using the more varied choices.
References
Andarmoyo, S., Yusoff, H. B. M., Bin Abdullah, B., & Yusop, Y. B. M. (2019). Medication Adherence Analysis of Type 2 Diabetes Mellitus Patients. South East Asia Nursing Research, 1(3), 107. https://doi.org/10.26714/seanr.1.3.2019.107-111
Anggraini, D., Puspasari, N., Tinggi, S., & Kesehatan Nasional, I. (2019). Tingkat Kepatuhan Penggunaan Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe 2 Di Apotek Sehat Kabupaten Boyolali The level of Compliance with The Use of Antidiabetic Drugs In Type 2 Diabetes Mellitus Patients In Apotek Sehat Regency of Boyolali. IJMS-Indonesian Journal On Medical Science, 6(2).
ADA (2021). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care, 44(January), S15–S33. https://doi.org/10.2337/dc21-S002
BPOM. (2006). Faktor Penting dalam Keberhasilan Terapi. Infopom, 7(5), 1–12.
Depkes, R. I. (2007). Pedoman konseling pelayanan kefarmasian di sarana kesehatan. Jakarta: Departemen Kesehatan RI Direktorat Bina Farmasi Komunitas Dan Klinik.
Fajriyah, N. N., Ningrum, W. A., Muthoharoh, A., & Listiana, T. (2019). Hubungan Karakteristik dengan Tingkat Kepatuhan Penggunaan Obat Pada Diabetisi Tipe 2 Prolanis Di Wilayah Kerja Puskesmas Wonopringgo Kabupaten Pekalongan. Gombong : Urecol. University Research Colloquium, 41(9), 2045–2047.
Hannan, M. (2013). Analisis Faktor Yang Mempengaruhi Kepatuhan Minum Obat Pada Pasien Diabetes Mellitus Di Puskesmas Bluto Sumenep. Wiraraja Medika, 3(2), 47–55. https://www.ejournalwiraraja.com/index.php/FIK/article/view/72
IDF. (2017). International Diabetes Federation (2015). Diabetes Atlas, Seventh Edition: Www. Diabetesatlas. Org Accessed August, 2015.
IDF. (2019). IDF Diabetes Atlas. https://www.diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html
Isnaini, N., & Ratnasari, R. (2018). Faktor risiko mempengaruhi kejadian Diabetes mellitus tipe dua. Jurnal Kebidanan Dan Keperawatan Aisyiyah, 14(1), 59–68.
Jasmine, N. S. (2019). Faktor – Faktor Yang Berhubungan Terhadap Tingkat Kepatuhan Minum Obat Pada Pasien Diabetes Melitus Di Puskesmas Pancoran Mas Depok Periode Maret – April 2019. April, 10–11.
Jasmine, N. S., Wahyuningsih, S., & Thadeus, M. S. (2020). Analisis Faktor Tingkat Kepatuhan Minum Obat Pasien Diabetes Melitus di Puskesmas Pancoran Mas Periode Maret – April 2019. Jurnal Manajemen Kesehatan Indonesia, 8(1), 61–66. https://ejournal.undip.ac.id/index.php/jmki/article/view/24742
Jateng, D. (2020). Profil Kesehatan Provinsi Jawa Tengah Tahun 2020. http://dinkesjatengprov.go.id/v2018/dokumen/profilkesehatan2020/mobile/index.html
Julaiha, S. (2019). Analisis Faktor Kepatuhan Berobat Berdasarkan Skor MMAS-8 pada Pasien Diabetes Mellitus Tipe 2. Jurnal Kesehatan, 10(2), 203. https://doi.org/10.26630/jk.v10i2.1267
Kartika, T. T. (2018). Kepatuhan Penggunaan Obat pada Pasien Diabetes Melitus di Puskesmas Pucang Sewu Surbaya. SKRIPSI, 7(2), 44–68.
Kemenkes RI. (2016). Diabetes. Info Datin, 161(5), 1058–1063.
Kemenkes RI. (2020). Infodatin Pusat Data dan Informasi Kementrian Kesehaan Republik Indonesia Tetap Produktif, Cegah, dan Atasi. 10. https://www.kemkes.go.id/download.php?file=download/pusdatin/infodatin/Infodatin 2020 Diabetes Melitus.pdf
Malfirani, L., Nurmainah, & Purwanti, N. U. (2018). Analisis Kepatuhan Pengobatan Pasien Diabetes Melitus Tipe 2 Rawat Jalan Di Puskesmas Kampung Bangka Pontianak Tenggara Periode Juli 2017 - Desember 2018. Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN, 33(1), 8–18.
Meidikayanti, W., & Wahyuni, C. U. (2017). Hubungan Dukungan Keluarga dengan Kualitas Hidup Diabetes Melitus Tipe 2 Di Puskesmas Pademawu. Jurnal Berkala Epidemiologi, 5(2), 240–252. https://doi.org/10.20473/jbe.v5i2.2017.240-252
Mokolomban, C., Wiyono, W. I., & Mpila, D. A. (2018). Kepatuhan Minum Obat Pada Pasien Diabetes Melitus Tipe 2 Disertai Hipertensi Dengan Menggunakan Metode Mmas-8. Pharmacon, 7(4), 69–78.
Mulyani, L. (2021). Evaluasi Kepatuhan Penggunaan Obat pada Psien Diabetes Melitus Tipe 2 di Puskesmas Kuwarasan. SKRIPSI.
Pascal, I. G. U., Ofoedu, J. N., Uchenna, N. P., Nkwa, A. A., & Uchamma, G. U. E. (2012). Blood glucose control and medication adherence among adult type 2 diabetic Nigerians attending a primary care clinic in under-resourced environment of eastern Nigeria. North American Journal of Medical Sciences, 4(7), 310–315. https://doi.org/10.4103/1947-2714.98590
Perkeni. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Perkumpulan Endokrinologi Indonesia, 46. www.ginasthma.org.
Rasdianah, N., Martodiharjo, S., Andayani, T. M., & Hakim, L. (2016). Gambaran Kepatuhan Pengobatan Pasien Diabetes Melitus Tipe 2 di Puskesmas Daerah Istimewa Yogyakarta. Indonesian Journal of Clinical Pharmacy, 5(4), 249–257. https://doi.org/10.15416/ijcp.2016.5.4.249
Riskesdas. (2018). Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehatan RI, 53(9), 1689–1699.
Sammulia, S. F., Elfasyari, T. Y., & Pratama, M. R. (2020). Hubungan Karakteristik Pasien Diabetes Melitus Dan Tingkat Kepatuhan Minum Obat Di Rumah Sakit X Kota Batam. Jurnal JUMANTIK, 5(2), 138–146.
WHO. (2003). Adherence to Long-Term Therapies - Evidence for Action. Patient Preference and Adherence, 12, 2205–2216. https://doi.org/10.2147/PPA.S174652
WHO. (2019). Classification of diabetes mellitus. In Clinics in Laboratory Medicine (Vol. 21, Issue 1). https://doi.org/10.5005/jp/books/12855_84
